NCT03392402View on ClinicalTrials.gov

Molecular Classifier for the Fine Needle-based Assessment of Malignancy Risk in Thyroid Nodules

CompletedOBSERVATIONAL
Enrollment

599

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

March 31, 2020

Study Completion Date

December 31, 2020

Conditions
Thyroid NoduleThyroid NeoplasmThyroid Cancer
Trial Locations (1)

44-101

Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology, Gliwice

All Listed Sponsors
lead

Maria Sklodowska-Curie National Research Institute of Oncology

OTHER

NCT03392402 - Molecular Classifier for the Fine Needle-based Assessment of Malignancy Risk in Thyroid Nodules | Biotech Hunter | Biotech Hunter